{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T07:22:40Z","timestamp":1781508160441,"version":"3.54.1"},"reference-count":83,"publisher":"Bentham Science Publishers Ltd.","issue":"7","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPPS"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:sec><jats:title>Abstract:<\/jats:title><jats:p>Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system (CNS), including the brain, spinal cord, and optic nerves. The symptoms can vary from muscle weakness to vision loss. In the case of MS, the immune system attacks the myelin sheath, which protects the nerve fiber and causes inflammation resulting in demyelination. The myelin sheath has the composition of various proteins including membrane proteins and glycoproteins. The four main proteins namely Myelin Basic Protein (MBP), Myelin associated Oligodendrocyte Basic protein (MOBP), Myelin Proteolipid Protein (PLP) and Myelin Associated Glycoprotein (MAG) are known to be critical auto-antigens in causing demyelination in CNS leading to MS. Three out of these four proteins are intrinsically disordered proteins and in this review, we attempted to understand how these proteins play a crucial role in maintaining the integrity of myelin, by exploring its structural and functional aspects and also their auto-antigenicity leading to multiple sclerosis.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1389203724666230717124101","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T06:58:54Z","timestamp":1689663534000},"page":"579-588","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The Fulcrum of Demyelination in Multiple Sclerosis"],"prefix":"10.2174","volume":"24","author":[{"given":"Abinaya","family":"Ganesan","sequence":"first","affiliation":[{"name":"Department of Biotechnology, School of Chemical and Biotechnology, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, 613401, Tamil Nadu, India"},{"name":"Computational and Molecular Biophysics Laboratory, School of Chemical and Biotechnology, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, 613401, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Muralidharan","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, School of Chemical and Biotechnology, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, 613401, Tamil Nadu, India"},{"name":"Computational and Molecular Biophysics Laboratory, School of Chemical and Biotechnology, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, 613401, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi Narasimhan","family":"Ramya","sequence":"additional","affiliation":[{"name":"Computational and Molecular Biophysics Laboratory, School of Chemical and Biotechnology, SASTRA Deemed University, Thirumalaisamudram, Thanjavur, 613401, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","author":"Libretti S.","year":"2023","unstructured":"Libretti S.; Puckett Y.; Physiology, Homeostasis 2023","journal-title":"Physiology, Homeostasis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4103\/0019-5545.33264","volume":"49","author":"RajMohan V.","year":"2007","unstructured":"RajMohan V.; Mohandas E.; The limbic system. Indian J Psychiatry 2007,49(2),132-139","journal-title":"Indian J Psychiatry"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.3389\/fpsyg.2017.01454","volume":"8","author":"Tyng C.M.","year":"2017","unstructured":"Tyng C.M.; Amin H.U.; Saad M.N.M.; Malik A.S.; The influences of emotion on learning and memory. Front Psychol 2017,8(1454),1454","journal-title":"Front Psychol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/neuro.09.031.2009","volume":"3","author":"Herculano-Houzel S.","year":"2009","unstructured":"Herculano-Houzel S.; The human brain in numbers: A linearly scaled-up primate brain. Front Hum Neurosci 2009,3,31","journal-title":"Front Hum Neurosci"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ar.23728","volume":"301","author":"Bahney J.","year":"2018","unstructured":"Bahney J.; von Bartheld C.S.; The cellular composition and glia-neuron ratio in the spinal cord of a human and a nonhuman primate: Comparison with other species and brain regions. Anat Rec 2018,301(4),697-710","journal-title":"Anat Rec"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"573256","DOI":"10.3389\/fimmu.2020.573256","volume":"11","author":"Linnerbauer M.","year":"2020","unstructured":"Linnerbauer M.; Rothhammer V.; Protective functions of reactive astrocytes following central nervous system insult. Front Immunol 2020,11,573256","journal-title":"Front Immunol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/cells9020482","volume":"9","author":"Kunkl M.","year":"2020","unstructured":"Kunkl M.; Frascolla S.; Amormino C.; Volpe E.; Tuosto L.; T helper cells: The modulators of inflammation in multiple sclerosis. Cells 2020,9(2),482","journal-title":"Cells"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3390\/biom9040147","volume":"9","author":"Kulkarni P.","year":"2019","unstructured":"Kulkarni P.; Uversky VN.; Intrinsically disordered proteins in chronic diseases. Biomolecules 2019,9(4),147","journal-title":"Biomolecules"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11011-021-00791-8","volume":"37","author":"Ayyadevara S.","year":"2022","unstructured":"Ayyadevara S.; Ganne A.; Balasubramaniam M.; Shmookler Reis R.J.; Intrinsically disordered proteins identified in the aggregate proteome serve as biomarkers of neurodegeneration. Metab Brain Dis 2022,37(1),147-152","journal-title":"Metab Brain Dis"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s12551-022-00968-0","volume":"14","author":"Coskuner-Weber O.","year":"2022","unstructured":"Coskuner-Weber O.; Mirzanli O.; Uversky VN.; Intrinsically disordered proteins and proteins with intrinsically disordered regions in neurodegenerative diseases. Biophys Rev 2022,14(3),679-707","journal-title":"Biophys Rev"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1039\/b900658n","volume":"5","author":"Jeffery C.J.","year":"2009","unstructured":"Jeffery C.J.; Moonlighting proteins\u2014an update. Mol Biosyst 2009,5(4),345-350","journal-title":"Mol Biosyst"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/bies.201100191","volume":"34","author":"Copley S.D.","year":"2012","unstructured":"Copley S.D.; Moonlighting is mainstream: Paradigm adjustment required. BioEssays 2012,34(7),578-588","journal-title":"BioEssays"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.autrev.2009.08.002","volume":"9","author":"Kaushansky N.","year":"2010","unstructured":"Kaushansky N.; Eisenstein M.; Zilkha-Falb R.; Ben-Nun A.; The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis. Autoimmun Rev 2010,9(4),233-236","journal-title":"Autoimmun Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/135245859900500303","volume":"5","author":"Schmidt S.","year":"1999","unstructured":"Schmidt S.; Candidate autoantigens in multiple sclerosis. Mult Scler 1999,5(3),147-160","journal-title":"Mult Scler"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1016\/j.jmb.2018.06.012","volume":"430","author":"Chen J.","year":"2018","unstructured":"Chen J.; Kriwacki R.W.; Intrinsically disordered proteins: Structure, function and therapeutics. J Mol Biol 2018,430(16),2275-2277","journal-title":"J Mol Biol"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cells9020470","volume":"9","author":"Raasakka A.","year":"2020","unstructured":"Raasakka A.; Kursula P.; Flexible players within the sheaths: The intrinsically disordered proteins of myelin in health and disease. Cells 2020,9(2),470","journal-title":"Cells"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF00749906","volume":"16","author":"Zhang J.","year":"1994","unstructured":"Zhang J.; Raus J.; Myelin basic protein-reactive T cells in multiple sclerosis: Pathologic relevance and therapeutic targeting. Cytotechnology 1994,16(3),181-187","journal-title":"Cytotechnology"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"Stadelmann C.","year":"2019","unstructured":"Stadelmann C.; Timmler S.; Barrantes-Freer A.; Simons M.; Myelin in the central nervous system: Structure, function, and pathology. Physiol Rev 2019,99(3),1381-1431","journal-title":"Physiol Rev"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"812","DOI":"10.3390\/cells9040812","volume":"9","author":"Poitelon Y.","year":"2020","unstructured":"Poitelon Y.; Kopec AM.; Belin S.; Myelin fat facts: An overview of lipids and fatty acid metabolism. Cells 2020,9(4),812","journal-title":"Cells"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00726-006-0479-7","volume":"34","author":"Kursula P.","year":"2008","unstructured":"Kursula P.; Structural properties of proteins specific to the myelin sheath. Amino Acids 2008,34(2),175-185","journal-title":"Amino Acids"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.18632\/aging.101032","volume":"8","author":"Choi C.I.","year":"2016","unstructured":"Choi C.I.; Yoo K.H.; Hussaini S.M.Q.; Jeon B.T.; Welby J.; Gan H.; Scarisbrick I.A.; Zhang Z.; Baker D.J.; van Deursen J.M.; Rodriguez M.; Jang M.H.; The progeroid gene BubR1 regulates axon myelination and motor function. Aging 2016,8(11),2667-2688","journal-title":"Aging"},{"key":"ref=22","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a020479","volume":"8","author":"Simons M.","year":"2016","unstructured":"Simons M.; Nave K.A.; Oligodendrocytes: Myelination and axonal support. Cold Spring Harb Perspect Biol 2016,8(1)","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrm.2017.138","volume":"19","author":"Harayama T.","year":"2018","unstructured":"Harayama T.; Riezman H.; Understanding the diversity of membrane lipid composition. Nat Rev Mol Cell Biol 2018,19(5),281-296","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12035-009-8071-2","volume":"40","author":"Jahn O.","year":"2009","unstructured":"Jahn O.; Tenzer S.; Werner H.B.; Myelin proteomics: molecular anatomy of an insulating sheath. Mol Neurobiol 2009,40(1),55-72","journal-title":"Mol Neurobiol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","volume":"59","author":"Love S.","year":"2006","unstructured":"Love S.; Demyelinating diseases. J Clin Pathol 2006,59(11),1151-1159","journal-title":"J Clin Pathol"},{"key":"ref=26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a028944","volume":"9","author":"Alfredsson L.","year":"2019","unstructured":"Alfredsson L.; Olsson T.; Lifestyle and environmental factors in multiple sclerosis. Cold Spring Harb Perspect Med 2019,9(4)","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2174\/0929867054039026","volume":"12","author":"Tzakos A.","year":"2005","unstructured":"Tzakos A.; Kursula P.; Troganis A.; Theodorou V.; Tselios T.; Svarnas C.; Matsoukas J.; Apostolopoulos V.; Gerothanassis I.; Structure and function of the myelin proteins: Current status and perspectives in relation to multiple sclerosis. Curr Med Chem 2005,12(13),1569-1587","journal-title":"Curr Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jcpa.2013.05.004","volume":"149","author":"Crawford A.H.","year":"2013","unstructured":"Crawford A.H.; Chambers C.; Franklin R.J.M.; Remyelination: The true regeneration of the central nervous system. J Comp Pathol 2013,149(2-3),242-254","journal-title":"J Comp Pathol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.pneurobio.2007.07.007","volume":"83","author":"Saxena S.","year":"2007","unstructured":"Saxena S.; Caroni P.; Mechanisms of axon degeneration: From development to disease. Prog Neurobiol 2007,83(3),174-191","journal-title":"Prog Neurobiol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00415-019-09421-x","volume":"268","author":"Cunniffe N.","year":"2021","unstructured":"Cunniffe N.; Coles A.; Promoting remyelination in multiple sclerosis. J Neurol 2021,268(1),30-44","journal-title":"J Neurol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1080\/14740338.2017.1388371","volume":"16","author":"Auricchio F.","year":"2017","unstructured":"Auricchio F.; Scavone C.; Cimmaruta D.; Di Mauro G.; Capuano A.; Sportiello L.; Rafaniello C.; Drugs approved for the treatment of multiple sclerosis: Review of their safety profile. Expert Opin Drug Saf 2017,16(12),1359-1371","journal-title":"Expert Opin Drug Saf"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-013-0030-6","volume":"73","author":"Ali R.","year":"2013","unstructured":"Ali R.; Nicholas R.S.J.; Muraro P.A.; Drugs in development for relapsing multiple sclerosis. Drugs 2013,73(7),625-650","journal-title":"Drugs"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202106150","volume":"174","author":"Olek M.J.","year":"2021","unstructured":"Olek M.J.; Multiple sclerosis. Ann Intern Med 2021,174(6),ITC81-ITC96","journal-title":"Ann Intern Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nrleng.2019.03.007","volume":"35","author":"Torre-Fuentes L.","year":"2020","unstructured":"Torre-Fuentes L.; Moreno-Jim\u00e9nez L.; Pytel V.; Mat\u00edas-Guiu J.A.; G\u00f3mez-Pinedo U.; Mat\u00edas-Guiu J.; Experimental models of demyelination and remyelination. Neurolog\u00eda 2020,35(1),32-39","journal-title":"Neurolog\u00eda"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.2174\/1389203723666220815110509","volume":"23","author":"Lakshmi Narasimhan R.","year":"2022","unstructured":"Lakshmi Narasimhan R.; Sharma G.; Gopinath S.; Exploring the molecular aspects of glycosylation in mog antibody disease (MOGAD). Curr Protein Pept Sci 2022,23(6),384-394","journal-title":"Curr Protein Pept Sci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3389\/fnins.2015.00138","volume":"9","author":"Siu C.R.","year":"2015","unstructured":"Siu C.R.; Balsor J.L.; Jones D.G.; Murphy K.M.; Classic and Golli Myelin Basic Protein have distinct developmental trajectories in human visual cortex. Front Neurosci 2015,9,138","journal-title":"Front Neurosci"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","volume":"54","author":"Martinsen V.","year":"2022","unstructured":"Martinsen V.; Kursula P.; Multiple sclerosis and myelin basic protein: Insights into protein disorder and disease. Amino Acids 2022,54(1),99-109","journal-title":"Amino Acids"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1021\/bi962649f","volume":"36","author":"Boggs J.M.","year":"1997","unstructured":"Boggs J.M.; Yip P.M.; Rangaraj G.; Jo E.; Effect of posttranslational modifications to myelin basic protein on its ability to aggregate acidic lipid vesicles. Biochemistry 1997,36(16),5065-5071","journal-title":"Biochemistry"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/0165-5728(93)90009-N","volume":"42","author":"Voskuhl R.R.","year":"1993","unstructured":"Voskuhl R.R.; McFarlin D.E.; Stone R.; McFarland H.F.; T-lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination. J Neuroimmunol 1993,42(2),187-191","journal-title":"J Neuroimmunol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/346183a0","volume":"346","author":"Ota K.","year":"1990","unstructured":"Ota K.; Matsui M.; Milford E.L.; Mackin G.A.; Weiner H.L.; Hafler D.A.; T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis. Nature 1990,346(6280),183-187","journal-title":"Nature"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1172\/JCI116242","volume":"91","author":"Valli A.","year":"1993","unstructured":"Valli A.; Sette A.; Kappos L.; Oseroff C.; Sidney J.; Miescher G.; Hochberger M.; Albert E.D.; Adorini L.; Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 1993,91(2),616-628","journal-title":"J Clin Invest"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1073\/pnas.0509158103","volume":"103","author":"Musse A.A.","year":"2006","unstructured":"Musse A.A.; Boggs J.M.; Harauz G.; Deimination of membrane-bound myelin basic protein in multiple sclerosis exposes an immunodominant epitope. Proc Natl Acad Sci 2006,103(12),4422-4427","journal-title":"Proc Natl Acad Sci"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1002\/prot.25590","volume":"86","author":"Meng F.","year":"2018","unstructured":"Meng F.; Kurgan L.; High\u2010throughput prediction of disordered moonlighting regions in protein sequences. Proteins 2018,86(10),1097-1110","journal-title":"Proteins"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.1021\/bi982960s","volume":"38","author":"Cao L.","year":"1999","unstructured":"Cao L.; Goodin R.; Wood D.; Moscarello M.A.; Whitaker J.N.; Rapid release and unusual stability of immunodominant peptide 45-89 from citrullinated myelin basic protein. Biochemistry 1999,38(19),6157-6163","journal-title":"Biochemistry"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1074\/mcp.M200050-MCP200","volume":"2","author":"Kim J.K.","year":"2003","unstructured":"Kim J.K.; Mastronardi F.G.; Wood D.D.; Lubman D.M.; Zand R.; Moscarello M.A.; Multiple sclerosis. Mol Cell Proteomics 2003,2(7),453-462","journal-title":"Mol Cell Proteomics"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410400106","volume":"40","author":"Wood D.D.","year":"1996","unstructured":"Wood D.D.; Moscarello M.A.; Bilbao J.M.; O\u2019Connors P.; Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein. Ann Neurol 1996,40(1),18-24","journal-title":"Ann Neurol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1159\/000017364","volume":"21","author":"Montague P.","year":"1999","unstructured":"Montague P.; Kirkham D.; McCallion A.S.; Davies R.W.; Kennedy P.G.E.; Klugmann M.; Nave K.A.; Griffiths I.R.; Reduced levels of a specific myelin-associated oligodendrocytic basic protein isoform in shiverer myelin. Dev Neurosci 1999,21(1),36-42","journal-title":"Dev Neurosci"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1007\/s00018-006-6094-7","volume":"63","author":"Boggs J.M.","year":"2006","unstructured":"Boggs J.M.; Myelin basic protein: A multifunctional protein. Cell Mol Life Sci 2006,63(17),1945-1961","journal-title":"Cell Mol Life Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1046\/j.1460-9568.1999.00490.x","volume":"11","author":"Yamamoto Y.","year":"1999","unstructured":"Yamamoto Y.; Yoshikawa H.; Nagano S.; Kondoh G.; Sadahiro S.; Gotow T.; Yanagihara T.; Sakoda S.; Myelin-associated oligodendrocytic basic protein is essential for normal arrangement of the radial component in central nervous system myelin. Eur J Neurosci 1999,11(3),847-855","journal-title":"Eur J Neurosci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s007950100009","volume":"34","author":"Yoshikawa H.","year":"2001","unstructured":"Yoshikawa H.; Myelin-associated oligodendrocytic basic protein modulates the arrangement of radial growth of the axon and the radial component of myelin. Med Electron Microsc 2001,34(3),160-164","journal-title":"Med Electron Microsc"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1002\/glia.10103","volume":"39","author":"Yool D.","year":"2002","unstructured":"Yool D.; Montague P.; McLaughlin M.; McCulloch M.C.; Edgar J.M.; Nave K.A.; Davies R.W.; Griffiths I.R.; McCallion A.S.; Phenotypic analysis of mice deficient in the major myelin protein MOBP, and evidence for a novelMobp isoform. Glia 2002,39(3),256-267","journal-title":"Glia"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1159\/000095110","volume":"28","author":"Montague P.","year":"2006","unstructured":"Montague P.; McCallion A.S.; Davies R.W.; Griffiths I.R.; Myelin-associated oligodendrocytic basic protein: A family of abundant CNS myelin proteins in search of a function. Dev Neurosci 2006,28(6),479-487","journal-title":"Dev Neurosci"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0165-5728(99)00168-X","volume":"102","author":"Kaye J.F.","year":"2000","unstructured":"Kaye J.F.; Kerlero de Rosbo N.; Mendel I.; Flechter S.; Hoffman M.; Yust I.; Ben-Nun A.; The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS). J Neuroimmunol 2000,102(2),189-198","journal-title":"J Neuroimmunol"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0165-5728(03)00080-8","volume":"137","author":"Arbour N.","year":"2003","unstructured":"Arbour N.; Holz A.; Sipe J.C.; Naniche D.; Romine J.S.; Zyroff J.; Oldstone M.B.; A new approach for evaluating antigen-specific T cell responses to myelin antigens during the course of multiple sclerosis. J Neuroimmunol 2003,137(1-2),197-209","journal-title":"J Neuroimmunol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.4049\/jimmunol.164.2.1103","volume":"164","author":"Holz A.","year":"2000","unstructured":"Holz A.; Bielekova B.; Martin R.; Oldstone M.B.A.; Myelin-associated oligodendrocytic basic protein: Identification of an encephalitogenic epitope and association with multiple sclerosis. J Immunol 2000,164(2),1103-1109","journal-title":"J Immunol"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s00726-011-0911-5","volume":"42","author":"Myllykoski M.","year":"2012","unstructured":"Myllykoski M.; Baumg\u00e4rtel P.; Kursula P.; Conformations of peptides derived from myelin-specific proteins in membrane-mimetic conditions probed by synchrotron radiation CD spectroscopy. Amino Acids 2012,42(4),1467-1474","journal-title":"Amino Acids"},{"key":"ref=57","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.172148","volume":"129","author":"Sch\u00e4fer I.","year":"2016","unstructured":"Sch\u00e4fer I.; M\u00fcller C.; Luhmann H.J.; White R.; MOBP levels are regulated by Fyn kinase and affect the morphological differentiation of oligodendrocytes. J Cell Sci 2016,129(5)","journal-title":"J Cell Sci"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/jnr.490310204","volume":"31","author":"Kamholz J.","year":"1992","unstructured":"Kamholz J.; Sessa M.; Scherer S.; Vogelbacker H.; Mokuno K.; Baron P.; Wrabetz L.; Shy M.; Pleasure D.; Structure and expression of proteolipid protein in the peripheral nervous system. J Neurosci Res 1992,31(2),231-244","journal-title":"J Neurosci Res"},{"key":"ref=59","first-page":"1","volume":"6","author":"Morell P.","year":"1999","unstructured":"Morell P.; Quarles R.H.; Characteristic composition of myelin. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 1999,6,1-10","journal-title":"Basic Neurochemistry: Molecular, Cellular and Medical Aspects"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000111420","volume":"18","author":"Knapp P.E.","year":"1996","unstructured":"Knapp P.E.; Proteolipid protein: Is it more than just a structural component of myelin? Dev Neurosci 1996,18(4),297-308","journal-title":"Dev Neurosci"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/glia.10014","volume":"37","author":"Sp\u00f6rkel O.","year":"2002","unstructured":"Sp\u00f6rkel O.; Uschkureit T.; B\u00fcssow H.; Stoffel W.; Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development. Glia 2002,37(1),19-30","journal-title":"Glia"},{"key":"ref=62","first-page":"1","volume":"2020","author":"Greer J.M.","year":"1891","unstructured":"Greer J.M.; Trifilieff E.; Pender M.P.; Correlation between anti-myelin proteolipid protein(PLP) antibodies and disease severity in multiple sclerosis patients with PLP response-permissive HLA types. Front Immunol 1891,2020(11),1-10","journal-title":"Front Immunol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00018-022-04428-6","volume":"79","author":"Ruskamo S","year":"2022","unstructured":"Ruskamo S; Raasakka A; Pedersen JS; Martel A; \u0160kubn\u00edk K; Darwish T; Porcar L; Kursula P; Human myelin proteolipid protein structure and lipid bilayer stacking. Cell Mol Life Sci 2022,79(8),419","journal-title":"Cell Mol Life Sci"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jaut.2008.04.018","volume":"31","author":"Greer J.M.","year":"2008","unstructured":"Greer J.M.; Pender M.P.; Myelin proteolipid protein: An effective autoantigen and target of autoimmunity in multiple sclerosis. J Autoimmun 2008,31(3),281-287","journal-title":"J Autoimmun"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.4049\/jimmunol.141.4.1126","volume":"141","author":"Tuohy V.K.","year":"1988","unstructured":"Tuohy V.K.; Lu Z.J.; Sobel R.A.; Laursen R.A.; Lees M.B.; A synthetic peptide from myelin proteolipid protein induces experimental allergic encephalomyelitis. J Immunol 1988,141(4),1126-1130","journal-title":"J Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/(SICI)1097-4547(19971001)50:1<13::AID-JNR2>3.0.CO;2-O","volume":"50","author":"Anderson T.J.","year":"1997","unstructured":"Anderson T.J.; Montague P.; Nadon N.; Nave K.A.; Griffiths I.R.; Modification of Schwann cell phenotype withPlp transgenes: Evidence that the PLP and DM20 isoproteins are targeted to different cellular domains. J Neurosci Res 1997,50(1),13-22","journal-title":"J Neurosci Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s004019900163","volume":"100","author":"Muller D.M.","year":"2000","unstructured":"Muller D.M.; Pender M.P.; Greer J.M.; A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol 2000,100(2),174-182","journal-title":"Acta Neuropathol"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.4049\/jimmunol.142.5.1523","volume":"142","author":"Tuohy V.K.","year":"1989","unstructured":"Tuohy V.K.; Lu Z.; Sobel R.A.; Laursen R.A.; Lees M.B.; Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 1989,142(5),1523-1527","journal-title":"J Immunol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"371","DOI":"10.4049\/jimmunol.156.1.371","volume":"156","author":"Greer J.M.","year":"1996","unstructured":"Greer J.M.; Sobel R.A.; Sette A.; Southwood S.; Lees M.B.; Kuchroo V.K.; Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 1996,156(1),371-379","journal-title":"J Immunol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/(SICI)1097-4547(19980715)53:2<143::AID-JNR3>3.0.CO;2-7","volume":"53","author":"Barrese N.","year":"1998","unstructured":"Barrese N.; Mak B.; Fisher L.; Moscarello M.A.; Mechanism of demyelination in DM20 transgenic mice involves increased fatty acylation. J Neurosci Res 1998,53(2),143-152","journal-title":"J Neurosci Res"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"6907","DOI":"10.4049\/jimmunol.166.11.6907","volume":"166","author":"Greer J.M.","year":"2001","unstructured":"Greer J.M.; Denis B.; Sobel R.A.; Trifilieff E.; Thiopalmitoylation of myelin proteolipid protein epitopes enhances immunogenicity and encephalitogenicity. J Immunol 2001,166(11),6907-6913","journal-title":"J Immunol"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.4049\/jimmunol.180.3.1398","volume":"180","author":"Pfender N.A.","year":"2008","unstructured":"Pfender N.A.; Grosch S.; Roussel G.; Koch M.; Trifilieff E.; Greer J.M.; Route of uptake of palmitoylated encephalitogenic peptides of myelin proteolipid protein by antigen-presenting cells: Importance of the type of bond between lipid chain and peptide and relevance to autoimmunity. J Immunol 2008,180(3),1398-1404","journal-title":"J Immunol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1046\/j.1471-4159.1999.731724.x","volume":"73","author":"Kursula P.","year":"1999","unstructured":"Kursula P.; Meril\u00e4inen G.; Lehto V.P.; Heape A.M.; The small myelin-associated glycoprotein is a zinc-binding protein. J Neurochem 1999,73(5),2110-2118","journal-title":"J Neurochem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nbd.2012.08.009","volume":"49","author":"Kinter J.","year":"2013","unstructured":"Kinter J.; Lazzati T.; Schmid D.; Zeis T.; Erne B.; L\u00fctzelschwab R.; Steck A.J.; Pareyson D.; Peles E.; Schaeren-Wiemers N.; An essential role of MAG in mediating axon\u2013myelin attachment in Charcot\u2013Marie\u2013Tooth 1A disease. Neurobiol Dis 2013,49,221-231","journal-title":"Neurobiol Dis"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"070214184024009","DOI":"10.1111\/j.1471-4159.2006.04319.x","volume":"0","author":"Quarles R.H.","year":"2007","unstructured":"Quarles R.H.; Myelin-associated glycoprotein (MAG): Past, present and beyond. J Neurochem 2007,0(0),070214184024009-???","journal-title":"J Neurochem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1073\/pnas.84.2.600","volume":"84","author":"Arquint M.","year":"1987","unstructured":"Arquint M.; Roder J.; Chia L.S.; Down J.; Wilkinson D.; Bayley H.; Braun P.; Dunn R.; Molecular cloning and primary structure of myelin-associated glycoprotein. Proc Natl Acad Sci 1987,84(2),600-604","journal-title":"Proc Natl Acad Sci"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/jnr.490240203","volume":"24","author":"Spagnol G.","year":"1989","unstructured":"Spagnol G.; Williams M.; Srinivasan J.; Golier J.; Bauer D.; Lebo R.V.; Latov N.; Molecular cloning of human myelin-associated glycoprotein. J Neurosci Res 1989,24(2),137-142","journal-title":"J Neurosci Res"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jnr.490330303","volume":"33","author":"Yim S.H.","year":"1992","unstructured":"Yim S.H.; Quarles R.H.; Biosynthesis and expression of the myelin-associated glycoprotein in cultured oligodendrocytes from adult bovine brain. J Neurosci Res 1992,33(3),370-378","journal-title":"J Neurosci Res"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1111\/j.1471-4159.1992.tb09335.x","volume":"58","author":"Burger D.","year":"1992","unstructured":"Burger D.; Perruisseau G.; Simon M.; Steck A.J.; Comparison of the N-linked oligosaccharide structures of the two major human myelin glycoproteins MAG and P0: Assessment of the structures bearing the epitope for HNK-1 and human monoclonal immunoglobulin M found in demyelinating neuropathy. J Neurochem 1992,58(3),854-861","journal-title":"J Neurochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-5728(89)90009-X","volume":"22","author":"M\u00f6ller J.R.","year":"1989","unstructured":"M\u00f6ller J.R.; Johnson D.; Brady R.O.; Tourtellotte W.W.; Quarles R.H.; Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 1989,22(1),55-61","journal-title":"J Neuroimmunol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"13584","DOI":"10.1038\/ncomms13584","volume":"7","author":"Pronker MF.","year":"2016","unstructured":"Pronker MF.; Lemstra S.; Snijder J.; Heck AJ.; Thies-Weesie DM.; Pasterkamp RJ.; Janssen BJ.; Structural basis of myelin-associated glycoprotein adhesion and signalling. Nat Commun 2016,7,13584","journal-title":"Nat Commun"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1468-1331.2002.00391.x","volume":"9","author":"Andersson M.","year":"2002","unstructured":"Andersson M.; Yu M.; S\u00f6derstr\u00f6m M.; Weerth S.; Baig S.; Linington C.; Solders G.; Link H.; Multiple MAG peptides are recognized by circulating T and B lymphocytes in polyneuropathy and multiple sclerosis. Eur J Neurol 2002,9(3),243-251","journal-title":"Eur J Neurol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1471-4159.1982.tb12551.x","volume":"37","author":"Figlewicz D.A.","year":"1982","unstructured":"Figlewicz D.A.; Quarles R.H.; Johnson D.; Barbarash G.R.; Sternberger N.H.; Biochemical demonstration of the myelin-associated glycoprotein in the peripheral nervous system. J Neurochem 1982,37(3),749-758","journal-title":"J Neurochem"}],"container-title":["Current Protein &amp; Peptide Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203724666230717124101","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/218797\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389203724666230717124101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T07:11:35Z","timestamp":1702797095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/218797\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389203724666230717124101","relation":{},"ISSN":["1389-2037"],"issn-type":[{"value":"1389-2037","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}